annual working capital:
$410.89M+$129.88M(+46.22%)Summary
- As of today (May 29, 2025), VRNA annual working capital is $410.89 million, with the most recent change of +$129.88 million (+46.22%) on December 31, 2024.
- During the last 3 years, VRNA annual working capital has risen by +$274.25 million (+200.71%).
- VRNA annual working capital is now at all-time high.
Performance
VRNA Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$444.48M+$33.59M(+8.17%)Summary
- As of today (May 29, 2025), VRNA quarterly working capital is $444.48 million, with the most recent change of +$33.59 million (+8.17%) on March 31, 2025.
- Over the past year, VRNA quarterly working capital has increased by +$187.41 million (+72.91%).
- VRNA quarterly working capital is now at all-time high.
Performance
VRNA quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
VRNA Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.2% | +72.9% |
| 3 y3 years | +200.7% | +286.3% |
| 5 y5 years | +891.1% | +1437.3% |
VRNA Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +200.7% | at high | +345.5% |
| 5 y | 5-year | at high | +891.1% | at high | +2048.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
VRNA Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $444.48M(+8.2%) |
| Dec 2024 | $410.89M(+46.2%) | $410.89M(+22.2%) |
| Sep 2024 | - | $336.30M(-8.6%) |
| Jun 2024 | - | $367.95M(+43.1%) |
| Mar 2024 | - | $257.07M(-8.5%) |
| Dec 2023 | $281.02M(+25.5%) | $281.02M(+5.0%) |
| Sep 2023 | - | $267.51M(-3.4%) |
| Jun 2023 | - | $276.88M(-1.2%) |
| Mar 2023 | - | $280.37M(+25.2%) |
| Dec 2022 | $223.97M(+63.9%) | $223.97M(-1.0%) |
| Sep 2022 | - | $226.33M(+126.9%) |
| Jun 2022 | - | $99.77M(-13.3%) |
| Mar 2022 | - | $115.05M(-15.8%) |
| Dec 2021 | $136.64M(-27.4%) | $136.64M(-12.8%) |
| Sep 2021 | - | $156.75M(-0.7%) |
| Jun 2021 | - | $157.92M(-10.2%) |
| Mar 2021 | - | $175.90M(-6.6%) |
| Dec 2020 | $188.30M(+354.2%) | $188.30M(-3.7%) |
| Sep 2020 | - | $195.62M(+845.3%) |
| Jun 2020 | - | $20.69M(-28.4%) |
| Mar 2020 | - | $28.91M(-30.3%) |
| Dec 2019 | $41.46M(-46.8%) | $41.46M(-11.9%) |
| Sep 2019 | - | $47.04M(-22.9%) |
| Jun 2019 | - | $61.00M(-17.0%) |
| Mar 2019 | - | $73.49M(-5.7%) |
| Dec 2018 | $77.96M | $77.96M(-6.0%) |
| Sep 2018 | - | $82.98M(-2.8%) |
| Jun 2018 | - | $85.40M(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $89.89M(-15.2%) |
| Dec 2017 | $106.06M(+161.0%) | $106.06M(-5.3%) |
| Sep 2017 | - | $112.02M(-6.0%) |
| Jun 2017 | - | $119.17M(+193.2%) |
| Dec 2016 | $40.64M(+629.6%) | $40.64M(+1232.6%) |
| Jun 2016 | - | $3.05M(-45.2%) |
| Dec 2015 | $5.57M(-66.7%) | $5.57M(-52.2%) |
| Jun 2015 | - | $11.64M(-30.3%) |
| Dec 2014 | $16.71M(+2682.4%) | $16.71M(-18.4%) |
| Jun 2014 | - | $20.47M(+3309.3%) |
| Dec 2013 | $600.40K(-61.7%) | $600.40K(-59.0%) |
| Jun 2013 | - | $1.47M(-6.4%) |
| Dec 2012 | $1.57M(-59.0%) | $1.57M(-59.2%) |
| Jun 2012 | - | $3.84M(+0.6%) |
| Dec 2011 | $3.82M(+32.7%) | $3.82M(+123.0%) |
| Jun 2011 | - | $1.71M(-40.5%) |
| Dec 2010 | $2.88M(-39.1%) | $2.88M(-34.5%) |
| Jun 2010 | - | $4.40M(-7.0%) |
| Dec 2009 | $4.73M(+32.4%) | $4.73M(+70.9%) |
| Jun 2009 | - | $2.77M(-22.5%) |
| Dec 2008 | $3.57M(+34.8%) | $3.57M(-39.5%) |
| Jun 2008 | - | $5.90M(+122.7%) |
| Dec 2007 | $2.65M(-42.5%) | $2.65M(-30.2%) |
| Jun 2007 | - | $3.80M(-17.6%) |
| Dec 2006 | $4.60M(+173.3%) | $4.60M(+179.0%) |
| Jun 2006 | - | $1.65M(-2.0%) |
| Dec 2005 | $1.68M | $1.68M(-5.6%) |
| Jun 2005 | - | $1.78M |
FAQ
- What is Verona Pharma annual working capital?
- What is the all time high annual working capital for Verona Pharma?
- What is Verona Pharma annual working capital year-on-year change?
- What is Verona Pharma quarterly working capital?
- What is the all time high quarterly working capital for Verona Pharma?
- What is Verona Pharma quarterly working capital year-on-year change?
What is Verona Pharma annual working capital?
The current annual working capital of VRNA is $410.89M
What is the all time high annual working capital for Verona Pharma?
Verona Pharma all-time high annual working capital is $410.89M
What is Verona Pharma annual working capital year-on-year change?
Over the past year, VRNA annual working capital has changed by +$129.88M (+46.22%)
What is Verona Pharma quarterly working capital?
The current quarterly working capital of VRNA is $444.48M
What is the all time high quarterly working capital for Verona Pharma?
Verona Pharma all-time high quarterly working capital is $444.48M
What is Verona Pharma quarterly working capital year-on-year change?
Over the past year, VRNA quarterly working capital has changed by +$187.41M (+72.91%)